Maggie Banys‐Paluchowski

Efficacy of Lapatinib in Patients with HER2-Negative Metastatic Breast Cancer and HER2-Positive Circulating Tumor Cells—The DETECT III Clinical Trial

Tanja Fehm, Volkmar Mueller, Maggie Banys‐Paluchowski et al. · Clinical Chemistry · 2024 · 67 citations · Full text

Omission of Axillary Dissection Following Nodal Downstaging With Neoadjuvant Chemotherapy

Giacomo Montagna, Mary M. Mrdutt, Susie X. Sun et al. · JAMA Oncology · 2024 · 65 citations · Full text

Axillary surgery after neoadjuvant therapy in initially node-positive breast cancer: international EUBREAST survey

Maria Luisa Gasparri, Jana de Boniface, Philip Poortmans et al. · British journal of surgery · 2022 · 54 citations

Prognostic relevance of the HER2 status of circulating tumor cells in metastatic breast cancer patients screened for participation in the DETECT study program

Volkmar Müller, Maggie Banys‐Paluchowski, Thomas W. P. Friedl et al. · ESMO Open · 2021 · 52 citations · Full text

Abstract PD3-12: Efficacy of the tyrosine kinase inhibitor lapatinib in the treatment of patients with HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells - results from the randomized phase III DETECT III trial

Tanja Fehm, Volkmar Mueller, Maggie Banys‐Paluchowski et al. · Cancer Research · 2021 · 27 citations

Tumor Biology, Abstract Pd3-12, Breast Oncology +12